Lupus :: Gene linked to Lupus
Lupus occurs when the immune system misfires and attacks the body’s organs and tissues. Nobody knows exactly why this happens, but a new study points to one possible cause.
University
Cervical Cancer :: New cervical cancer vaccine to be evaluated in Rochester
Rochester has been chosen as one of four national sites to monitor the effectiveness of the new cervical cancer vaccine. The project, which is funded by the national Centers for Disease Control and Prevention (CDC), will be jointly conducted by the University of Rochester Medical Center (URMC) and the New York State Department of Health.
Multiple Sclerosis :: Waddell Center Experts Conduct Multiple Sclerosis Symposium
Clinicians from the Waddell Center for Multiple Sclerosis will conduct MS Symposium 2007: Education, Support and Solutions, a free event for patients, caregivers and health care providers, on Saturday, Oct. 6, at the Oasis Conference Center in Loveland. The Waddell Center is an affiliate of UC Physicians and the Neuroscience Institute at University Hospital and the University of Cincinnati (UC).
Diarrhea :: Iomai vaccine patch for Travelers’ Diarrhea effective
Iomai Corporation (Nasdaq: IOMI) announced that travelers who received the company’s patch-based travelers’ diarrhea vaccine were significantly less likely to be sickened as compared with travelers who receive a placebo, according to research presented today by Chief Scientific Officer Gregory Glenn, M.D. at a late-breaker presentation during the “Vaccines and Pediatric Infections” session of the 47th Interscience Conference on Antimicrobial Agents and Chemotherapy being held in Chicago.
Tuberculosis :: $280 m grants to fight tuberculosis epidemic – Bill & Melinda Gates Foundation
The Bill & Melinda Gates Foundation announced grants totaling $280 million to help fight tuberculosis, an epidemic that infects one-third of people on earth and kills nearly 2 million yearly—mostly in the poorest countries.
Dialysis :: Hemodialysis at night improves outcomes for kidney disease patients
Patients who received hemodialysis at night six times a week for treatment of end-stage kidney disease had improvements on certain outcomes, including reduced need for blood pressure medications and improvement in selected quality of life measures, compared to patients who received conventional hemodialysis three times weekly, according to an article in the September 19 issue of JAMA.
Health :: UT Southwestern earns $34M NIH grant to foster patient-oriented research
UT Southwestern Medical Center will receive $34 million from the National Institutes of Health to lead a wide-ranging collaborative initiative aimed at speeding the transfer of laboratory discoveries to new therapies that improve human health.
Diabetes :: Novartis’ Galvus efficacious in treating patients with type 2 diabetes
Uncontrolled patients with type 2 diabetes treated with metformin, one of the most prescribed oral medicines for this disease, were four times more likely to achieve recommended blood sugar control levels by adding Galvus® (vildagliptin) to their treatment compared to those who added a placebo, according to new clinical data[1].
Osteoporosis :: Aclasta Reclast prevents additional fractures in hip fracture patients with osteoporosis
Results of the first-ever clinical study in patients with osteoporosis who suffered a hip fracture show that a once-yearly infusion of Aclasta®/Reclast® (zoledronic acid 5 mg)[*] reduced the risk of subsequent fractures by 35% compared to patients treated with placebo.
Parkinson’s Disease :: Gene abnormality tied to getting Parkinson’s disease at a younger age
People with a certain gene mutation are more likely to get Parkinson’s disease before the age of 50 compared to those without the gene abnormality, according to a study published in the September 18, 2007, issue of Neurology®, the medical journal of the American Academy of Neurology.